会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NEURAL MODULATION DEVICES AND METHODS
    • 神经调制装置及方法
    • US20160317808A1
    • 2016-11-03
    • US15147280
    • 2016-05-05
    • EnteroMedics Inc.
    • Katherine S. TwedenJonathan J. WaatajaAdrianus P. DondersMark B. Knudson
    • A61N1/36A61N1/378A61N1/372A61N1/05
    • A61N1/36007A61N1/0509A61N1/0551A61N1/36053A61N1/36085A61N1/36117A61N1/36171A61N1/36178A61N1/37235A61N1/3787
    • A system for designing a therapy or for treating a gastrointestinal disorder or a condition associated with excess weight in a subject comprising at least one electrode configured to be implanted within a body of the patient and placed at a vagus nerve, the electrode also configured to apply therapy to the vagus nerve upon application of a therapy cycle to the electrode; an implantable neuroregulator for placement in the body of the patient beneath the skin layer, the implantable neuroregulator being configured to generate a therapy cycle, wherein the therapy cycle comprises an on time during which an electrical signal is delivered, the electrical signal comprising: a) a set of pulses applied at a first selected frequency of about 150-10,000 Hz, wherein each pulse of the set of pulses has a pulse width of at least 0.01 milliseconds and less than the period of the first selected frequency.
    • 一种用于设计用于治疗或治疗与受试者相关的胃肠疾病或与体重过重相关的病症的系统,所述系统包括至少一个被配置成植入患者体内并置于迷走神经的电极,所述电极还被配置为施加 在向电极施加治疗周期时对迷走神经进行治疗; 可植入神经调节器,用于放置在皮肤层下面的患者体内,所述可植入神经调节器被配置为产生治疗周期,其中所述治疗周期包括传递电信号的接通时间,所述电信号包括:a) 以大约150-10,000Hz的第一选定频率施加的一组脉冲,其中脉冲组的每个脉冲具有至少0.01毫秒且小于第一选定频率的周期的脉冲宽度。
    • 4. 发明授权
    • Electrode band system and methods of using the system to treat obesity
    • 电极带系统和使用该系统治疗肥胖的方法
    • US08862233B2
    • 2014-10-14
    • US13758223
    • 2013-02-04
    • EnteroMedics Inc.
    • Mark B. KnudsonRichard R. WilsonKatherine S. TwedenTimothy R. Conrad
    • A61N1/372A61N1/36A61F5/37A61F5/00A61N1/32A61N1/05
    • A61N1/36053A61F5/0026A61N1/05A61N1/321A61N1/36007A61N1/36071A61N1/36082A61N1/37235
    • At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is obesity. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to, at least in part, downregulate neural activity on the vagus nerve. In embodiments, a system comprises a band comprising a first electrode array and a second electrode array; a signal generator electrically connected to each of said first, and second electrode array; an external programmer configured to: communicate at least one parameter for the neural conduction blocking signal to the implantable controller, wherein the parameter is selected for the neuroconduction blocking signal to i) at least partially downregulate the vagus nerve, ii) allow at least partial recovery of the nerve activity following discontinuation of the neural conduction blocking signal, and iii) reduce pancreatic and biliary output via inhibition of pancreo-biliary output; and an external coil.
    • 通过包括将电极定位在迷走神经上的方法来治疗至少部分地由支配患者的多个器官中的至少一个的迷走神经活动表征的患者的多种病症中的至少一种。 将电信号施加到电极,以通过选择用于治疗病症的量来调节迷走神经活性。 在一些实施方案中,该疾病是肥胖症。 该信号可以是阻塞或刺激信号。 在一些实施方案中,所述信号被选择为至少部分地下调迷走神经的神经活动。 在实施例中,系统包括包括第一电极阵列和第二电极阵列的带; 电连接到所述第一和第二电极阵列中的每一个的信号发生器; 外部编程器被配置为:将至少一个用于所述神经传导阻断信号的参数传达到所述可植入控制器,其中为所述神经传导阻断信号选择所述参数以i)至少部分地下调迷走神经,ii)允许至少部分恢复 神经传导阻滞信号停止后的神经活动,以及iii)通过抑制胰胆管输出来减少胰腺和胆汁输出; 和外部线圈。
    • 6. 发明申请
    • METHODS AND SYSTEMS FOR GLUCOSE REGULATION
    • 葡萄糖调节方法与系统
    • US20170021174A1
    • 2017-01-26
    • US15098704
    • 2016-04-14
    • EnteroMedics, Inc.
    • Arnold W. ThorntonDennis Dong-won KimMark B. KnudsonKatherine S. TwedenRichard R. Wilson
    • A61N1/36A61N1/372A61N1/05
    • A61N1/36053A61M5/00A61N1/0551A61N1/36007A61N1/36167A61N1/37211A61N1/37235
    • Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    • 用于治疗与受试者中的葡萄糖调节受损有关的病症的各种方法和装置包括在一个实施方案中,将神经传导阻滞物施用于至少部分阻断神经脉冲的神经传导阻滞位置处的阻断部位的靶神经。 在另一个实施方案中,下调和/或上调与或不与药剂的组合用于治疗葡萄糖调节受损。 在其他实施方案中,使用诸如迷走神经及其分支以及内脏的各种神经的上调或下调来改变GLP-1和GIP的产生,从而控制葡萄糖水平。 在另外的实施方案中,使用具有或不具有药剂的下调和/或上调的组合来改变GLP-1和GIP的产生,以治疗葡萄糖调节受损。
    • 10. 发明授权
    • Neural modulation devices and methods
    • 神经调制装置及方法
    • US09358395B2
    • 2016-06-07
    • US14453183
    • 2014-08-06
    • EnteroMedics Inc.
    • Katherine S. TwedenJonathan J. WaatajaAdrianus P. DondersMark B. Knudson
    • A61N1/36A61N1/05A61N1/372A61N1/378
    • A61N1/36007A61N1/0509A61N1/0551A61N1/36053A61N1/36085A61N1/36117A61N1/36171A61N1/36178A61N1/37235A61N1/3787
    • A system for designing a therapy or for treating a gastrointestinal disorder or a condition associated with excess weight in a subject comprising at least one electrode configured to be implanted within a body of the patient and placed at a vagus nerve, the electrode also configured to apply therapy to the vagus nerve upon application of a therapy cycle to the electrode; an implantable neuroregulator for placement in the body of the patient beneath the skin layer, the implantable neuroregulator being configured to generate a therapy cycle, wherein the therapy cycle comprises an on time during which an electrical signal is delivered, the electrical signal comprising: a) a set of pulses applied at a first selected frequency of about 150-10,000 Hz, wherein each pulse of the set of pulses has a pulse width of at least 0.01 milliseconds and less than the period of the first selected frequency.
    • 一种用于设计用于治疗或治疗与受试者相关的胃肠疾病或与体重过重相关的病症的系统,所述系统包括至少一个被配置成植入患者体内并置于迷走神经的电极,所述电极还被配置为施加 在向电极施加治疗周期时对迷走神经进行治疗; 可植入神经调节器,用于放置在皮肤层下面的患者体内,所述可植入神经调节器被配置为产生治疗周期,其中所述治疗周期包括传递电信号的接通时间,所述电信号包括:a) 以大约150-10,000Hz的第一选定频率施加的一组脉冲,其中脉冲组的每个脉冲具有至少0.01毫秒且小于第一选定频率的周期的脉冲宽度。